These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 28803840)

  • 1. Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials.
    Basu S; Sussman JB; Berkowitz SA; Hayward RA; Yudkin JS
    Lancet Diabetes Endocrinol; 2017 Oct; 5(10):788-798. PubMed ID: 28803840
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of Risk Equations for Complications of Type 2 Diabetes (RECODe) Using Individual Participant Data From Diverse Longitudinal Cohorts in the U.S.
    Basu S; Sussman JB; Berkowitz SA; Hayward RA; Bertoni AG; Correa A; Mwasongwe S; Yudkin JS
    Diabetes Care; 2018 Mar; 41(3):586-595. PubMed ID: 29269511
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of the CHIME simulation model to assess lifetime health outcomes of prediabetes and type 2 diabetes in Chinese populations: A modeling study.
    Quan J; Ng CS; Kwok HHY; Zhang A; Yuen YH; Choi CH; Siu SC; Tang SY; Wat NM; Woo J; Eggleston K; Leung GM
    PLoS Med; 2021 Jun; 18(6):e1003692. PubMed ID: 34166382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of prediction models for cardiovascular and mortality risk in people with type 2 diabetes: An external validation in 23 685 adults included in the UK Biobank.
    Zhang Y; Jiong OX; Tang S; Tang YC; Wong CT; Ng CS; Quan J
    Diabetes Obes Metab; 2024 May; 26(5):1697-1705. PubMed ID: 38297974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of optimal phenomapping methods to estimate long-term atherosclerotic cardiovascular disease risk in patients with type 2 diabetes.
    Segar MW; Patel KV; Vaduganathan M; Caughey MC; Jaeger BC; Basit M; Willett D; Butler J; Sengupta PP; Wang TJ; McGuire DK; Pandey A
    Diabetologia; 2021 Jul; 64(7):1583-1594. PubMed ID: 33715025
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk Prediction Scores for Type 2 Diabetes Microvascular and Cardiovascular Complications Derived and Validated With Real-world Data From 2 Provinces: The DIabeteS COmplications (DISCO) Risk Scores.
    Shah BR; Austin PC; Ivers NM; Katz A; Singer A; Sirski M; Thiruchelvam D; Tu K
    Can J Diabetes; 2024 Apr; 48(3):188-194.e5. PubMed ID: 38160936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adaptation of risk prediction equations for cardiovascular outcomes among patients with type 2 diabetes in real-world settings: a cross-institutional study using common data model approach.
    Yang CT; Chong KS; Wang CC; Ou HT; Kuo S
    Cardiovasc Diabetol; 2024 Jul; 23(1):244. PubMed ID: 38987773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study.
    Brownrigg JR; Hughes CO; Burleigh D; Karthikesalingam A; Patterson BO; Holt PJ; Thompson MM; de Lusignan S; Ray KK; Hinchliffe RJ
    Lancet Diabetes Endocrinol; 2016 Jul; 4(7):588-97. PubMed ID: 27216886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimizing Atherosclerotic Cardiovascular Disease Risk Estimation for Veterans With Diabetes Mellitus.
    Raghavan S; Ho YL; Vassy JL; Posner D; Honerlaw J; Costa L; Phillips LS; Gagnon DR; Wilson PWF; Cho K
    Circ Cardiovasc Qual Outcomes; 2020 Sep; 13(9):e006528. PubMed ID: 32862698
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvascular disease and cardiovascular outcomes among individuals with type 2 diabetes.
    Kaze AD; Santhanam P; Erqou S; Bertoni AG; Ahima RS; Echouffo-Tcheugui JB
    Diabetes Res Clin Pract; 2021 Jun; 176():108859. PubMed ID: 33989668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic importance of visit-to-visit blood pressure variability for micro- and macrovascular outcomes in patients with type 2 diabetes: The Rio de Janeiro Type 2 Diabetes Cohort Study.
    Cardoso CRL; Leite NC; Salles GF
    Cardiovasc Diabetol; 2020 May; 19(1):50. PubMed ID: 32359350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a model to predict cardiovascular death, nonfatal myocardial infarction, or nonfatal stroke in patients with type 2 diabetes mellitus and established atherosclerotic cardiovascular disease.
    Stevens SR; Segar MW; Pandey A; Lokhnygina Y; Green JB; McGuire DK; Standl E; Peterson ED; Holman RR
    Cardiovasc Diabetol; 2022 Aug; 21(1):166. PubMed ID: 36030198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Predicting macro- and microvascular complications in type 2 diabetes: the Japan Diabetes Complications Study/the Japanese Elderly Diabetes Intervention Trial risk engine.
    Tanaka S; Tanaka S; Iimuro S; Yamashita H; Katayama S; Akanuma Y; Yamada N; Araki A; Ito H; Sone H; Ohashi Y; ;
    Diabetes Care; 2013 May; 36(5):1193-9. PubMed ID: 23404305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive models for cardiovascular and kidney outcomes in patients with type 2 diabetes: systematic review and meta-analyses.
    Buchan TA; Malik A; Chan C; Chambers J; Suk Y; Zhu JW; Ge FZ; Huang LM; Vargas LA; Hao Q; Li S; Mustafa RA; Vandvik PO; Guyatt G; Foroutan F
    Heart; 2021 Dec; 107(24):1962-1973. PubMed ID: 33833070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys.
    Hajifathalian K; Ueda P; Lu Y; Woodward M; Ahmadvand A; Aguilar-Salinas CA; Azizi F; Cifkova R; Di Cesare M; Eriksen L; Farzadfar F; Ikeda N; Khalili D; Khang YH; Lanska V; León-Muñoz L; Magliano D; Msyamboza KP; Oh K; Rodríguez-Artalejo F; Rojas-Martinez R; Shaw JE; Stevens GA; Tolstrup J; Zhou B; Salomon JA; Ezzati M; Danaei G
    Lancet Diabetes Endocrinol; 2015 May; 3(5):339-55. PubMed ID: 25819778
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visit-to-Visit HbA
    Li S; Nemeth I; Donnelly L; Hapca S; Zhou K; Pearson ER
    Diabetes Care; 2020 Feb; 43(2):426-432. PubMed ID: 31727686
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivation and external validation of a risk prediction algorithm to estimate future risk of cardiovascular death among patients with type 2 diabetes and incident diabetic nephropathy: prospective cohort study.
    Yu D; Shang J; Cai Y; Wang Z; Zhang X; Zhao B; Zhao Z; Simmons D
    BMJ Open Diabetes Res Care; 2019; 7(1):e000735. PubMed ID: 31798896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lifetime and 10-year cardiovascular risk prediction in individuals with type 1 diabetes: The LIFE-T1D model.
    Helmink MAG; Hageman SHJ; Eliasson B; Sattar N; Visseren FLJ; Dorresteijn JAN; Harris K; Peters SAE; Woodward M; Szentkúti P; Højlund K; Henriksen JE; Sørensen HT; Serné EH; van Sloten TT; Thomsen RW; Westerink J
    Diabetes Obes Metab; 2024 Jun; 26(6):2229-2238. PubMed ID: 38456579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiovascular disease risk prediction equations in 400 000 primary care patients in New Zealand: a derivation and validation study.
    Pylypchuk R; Wells S; Kerr A; Poppe K; Riddell T; Harwood M; Exeter D; Mehta S; Grey C; Wu BP; Metcalf P; Warren J; Harrison J; Marshall R; Jackson R
    Lancet; 2018 May; 391(10133):1897-1907. PubMed ID: 29735391
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term Association of Depression Symptoms and Antidepressant Medication Use With Incident Cardiovascular Events in the Look AHEAD (Action for Health in Diabetes) Clinical Trial of Weight Loss in Type 2 Diabetes.
    Hazuda HP; Gaussoin SA; Wing RR; Yanovski SZ; Johnson KC; Coday M; Wadden TA; Horton ES; Van Dorsten B; Knowler WC;
    Diabetes Care; 2019 May; 42(5):910-918. PubMed ID: 30833373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.